American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care.

Autor:	Pennell NA; Cleveland Clinic, Cleveland, OH., Dillmon M; Harbin Clinic LLC, Rome, GA., Levit LA; American Society of Clinical Oncology, Alexandria, VA., Moushey EA; American Society of Clinical Oncology, Alexandria, VA., Alva AS; University of Michigan, Ann Arbor, MI., Blau S; Northwest Medical Specialties, Seattle, WA., Cannon TL; INOVA Medical Group, Fairfax, VA., Dickson NR; Tennessee Oncology, Nashville, TN., Diehn M; Stanford University, Stanford, CA., Gonen M; Memorial Sloan-Kettering Cancer Center, New York, NY., Gonzalez MM; Virginia Mason Medical Center, Seattle, WA., Hensold JO; Bozeman Deaconess Health Services, Bozeman, MT., Hinyard LJ; Saint Louis University, St Louis, MO., King T; Dana-Farber/Brigham and Women's Cancer Center, Boston, MA., Lindsey SC; Cholangiocarcinoma Foundation, Herriman, UT., Magnuson A; University of Rochester, Rochester, NY., Marron J; Boston Children's Hospital, Boston, MA., McAneny BL; New Mexico Oncology Hematology Consultants, Ltd, Albuquerque, NM., McDonnell TM; Seattle Cancer Care Alliance, Seattle, WA., Mileham KF; Levine Cancer Institute, Charlotte, NC., Nasso SF; National Coalition for Cancer Survivorship, Silver Spring, MD., Nowakowski GS; Mayo Clinic, Rochester, MN., Oettel KR; Gundersen Health System, La Crosse, WI., Patel MI; Stanford University, Stanford, CA., Patt DA; Texas Oncology PA, Austin, TX., Perlmutter J; Gemini Group, Ann Arbor, MI., Pickard TA; University of Texas MD Anderson Cancer Center, Houston, TX., Rodriguez G; START Center for Cancer Care, San Antonio, TX., Rosenberg AR; University of Washington, Seattle, WA., Russo B; The Center for Cancer and Blood Disorders, Fort Worth, TX., Szczepanek C; Cancer Research Consortium of West Michigan NCORP, Grand Rapids, MI., Smith CB; Icahn School of Medicine at Mt. Sinai, Bronxville, NY., Srivastava P; Kaiser Permanente Northern California, Walnut Creek, CA., Teplinsky E; Valley Health System, Paramus, NJ., Thota R; Intermountain Healthcare, South Jordan, UT., Traina TA; Memorial Sloan-Kettering Cancer Center, New York, NY., Zon R; Michiana Hematology Oncology, Niles, MI., Bourbeau B; American Society of Clinical Oncology, Alexandria, VA., Bruinooge SS; American Society of Clinical Oncology, Alexandria, VA., Foster S; Association for Clinical Oncology, Alexandria, VA., Grubbs S; American Society of Clinical Oncology, Alexandria, VA., Hagerty K; Association for Clinical Oncology, Alexandria, VA., Hurley P; American Society of Clinical Oncology, Alexandria, VA., Kamin D; American Society of Clinical Oncology, Alexandria, VA., Phillips J; American Society of Clinical Oncology, Alexandria, VA., Schenkel C; American Society of Clinical Oncology, Alexandria, VA., Schilsky RL; American Society of Clinical Oncology, Alexandria, VA., Burris HA 3rd; Sarah Cannon, Nashville, TN.
Jazyk:	angličtina
Zdroj:	Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Jan 10; Vol. 39 (2), pp. 155-169. Date of Electronic Publication: 2020 Dec 08.
DOI:	10.1200/JCO.20.02953
Abstrakt:	This report presents the American Society of Clinical Oncology's (ASCO's) evaluation of the adaptations in care delivery, research operations, and regulatory oversight made in response to the coronavirus pandemic and presents recommendations for moving forward as the pandemic recedes. ASCO organized its recommendations for clinical research around five goals to ensure lessons learned from the COVID-19 experience are used to craft a more equitable, accessible, and efficient clinical research system that protects patient safety, ensures scientific integrity, and maintains data quality. The specific goals are: (1) ensure that clinical research is accessible, affordable, and equitable; (2) design more pragmatic and efficient clinical trials; (3) minimize administrative and regulatory burdens on research sites; (4) recruit, retain, and support a well-trained clinical research workforce; and (5) promote appropriate oversight and review of clinical trial conduct and results. Similarly, ASCO also organized its recommendations regarding cancer care delivery around five goals: (1) promote and protect equitable access to high-quality cancer care; (2) support safe delivery of high-quality cancer care; (3) advance policies to ensure oncology providers have sufficient resources to provide high-quality patient care; (4) recognize and address threats to clinician, provider, and patient well-being; and (5) improve patient access to high-quality cancer care via telemedicine. ASCO will work at all levels to advance the recommendations made in this report.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu